| Literature DB >> 27865749 |
Asa Rahimi1, Gursev Anmole2, Maribel Soto-Nava3, Tania Escamilla-Gomez3, Tristan Markle2, Steven W Jin2, Guinevere Q Lee4, P Richard Harrigan4, David R Bangsberg5, Jeffrey Martin6, Santiago Avila-Rios3, Gustavo Reyes-Teran3, Mark A Brockman7, Zabrina L Brumme8.
Abstract
The HIV-1 accessory protein Vpu exhibits high inter- and intra- subtype genetic diversity that may influence Vpu function and possibly contribute to HIV-1 pathogenesis. However, scalable methods to evaluate genotype/phenotype relationships in natural Vpu sequences are limited, particularly those expressing the protein in CD4+ T-cells, the natural target of HIV-1 infection. A major impediment to assay scalability is the extensive genetic diversity within, and immediately upstream of, Vpu's initial 5' coding region, which has necessitated the design of oligonucleotide primers specific for each individual HIV-1 isolate (or subtype). To address this, we developed two universal forward primers, located in relatively conserved regions 38 and 90 bases upstream of Vpu, and a single universal reverse primer downstream of Vpu, which are predicted to cover the vast majority of global HIV-1 group M sequence diversity. We show that inclusion of up to 90 upstream bases of HIV-1 genomic sequence does not significantly influence in vitro Vpu expression or function when a Rev/Rev Response Element (RRE)-dependent expression system is used. We further assess the function of four diverse HIV-1 Vpu sequences, revealing reproducible and significant differences between them. Our approach represents a scalable option to measure the in vitro function of genetically diverse natural Vpu isolates in a CD4+ T-cell line.Entities:
Keywords: BST2/tetherin; CD4; Downregulation; HIV-1 Vpu; Rev/RRE; Sequence diversity
Mesh:
Substances:
Year: 2016 PMID: 27865749 PMCID: PMC5183569 DOI: 10.1016/j.jviromet.2016.11.004
Source DB: PubMed Journal: J Virol Methods ISSN: 0166-0934 Impact factor: 2.014